The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.

B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.

New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension. 

The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns.

State caps on malpractice damages were associated with a roughly 21% decrease in low-value imaging use for headaches, according to new Neiman Policy Institute research.  

Fellow radiologist Daniel Cousin, MD shared the unidentified individual’s story in an editorial published by KevinMD.com. 

The private equity-backed imaging group is initially launching artificial intelligence-enhanced breast imaging at clinics across Washington state. 

Family West Health, a 25-bed facility, said it spotted a cyberattack this week that forced it to shut down IT systems. However, it confirmed patient care was not impacted.

The U.S. Department of Justice says Nicole Millen—who is neither a medical doctor nor a veterinarian—gave visitors to her clinics Chorulon, a drug meant for cows, without properly labeling it as for animal use only.

The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration.